Question explored with the scientific record
What is the best solution or course of action to reverse male pattern baldness
The short version: the best evidence supports a combination of topical minoxidil and a 5α-reductase inhibitor, but the risk of persistent sexual side effects from oral finasteride is real and underreported in industry-funded trials.
Male pattern baldness is driven by dihydrotestosterone (DHT) shrinking hair follicles over time. The two drug classes that interrupt this process are topical minoxidil (a vasodilator that stimulates growth) and 5α-reductase inhibitors like finasteride and dutasteride, which lower DHT. A 2017 meta-analysis found that 1 mg oral finasteride added about 18 extra hairs per square centimeter, while 5% topical minoxidil added about 15 [5]. The combination consistently beats either alone: a 2015 Chinese trial of 450 men reported a 94% improvement rate with finasteride plus minoxidil, versus 80% with finasteride alone and 59% with minoxidil alone [6]. A 2002 Indian trial found the combination produced the strongest overall improvement, with 67% of patients rating it moderate or excellent [7].
The real question is whether the benefit is worth the side effects. The 2010 systematic review found that finasteride roughly doubles the risk of sexual dysfunction compared to placebo [3]. But the numbers from industry trials likely understate the problem. A 2016 retrospective study of 79 young men who stopped finasteride found that 87% still reported loss of penis sensitivity and 82% reported decreased ejaculatory force, on average 44 months after quitting [2]. The FDA post-marketing database has logged over 2,500 cases of sexual dysfunction, with at least 59 cases persisting for years [1]. This is not rare: the 2024 Brazilian review reported erectile dysfunction rates up to 38% [4].
| Treatment | Hair count gain (hairs/cm²) | Improvement rate | Key side effects |
|---|---|---|---|
| 5% topical minoxidil | ~15 [5] | 59% [6] | Scalp irritation, hypertrichosis |
| 1 mg oral finasteride | ~18 [5] | 80% [6] | Sexual dysfunction (2-38%), persistent in some [1, 2, 4] |
| Finasteride + minoxidil | Not separately measured | 94% [6] | Same as above, plus minoxidil side effects |
| Topical finasteride + minoxidil | ~62 hairs/cm² [9] | Not directly compared | Minimal systemic DHT reduction [9] |
| PRP injections | ~20-28 hairs/cm² [10] | Comparable to minoxidil [8] | Injection pain, cost |
The safest effective option is topical finasteride combined with minoxidil. A 2018 randomized trial of 0.25% topical finasteride plus 3% minoxidil found it increased hair density by 62 hairs per square centimeter with only a 5.7% drop in blood DHT, compared to the 60-70% drop from oral finasteride [9]. This avoids most of the systemic hormone disruption. If you want to avoid drugs entirely, pumpkin seed oil (which has weak 5α-reductase inhibiting properties) showed a 40% hair count increase over 24 weeks in a placebo-controlled trial [11], and low-level laser therapy added about 18 hairs per square centimeter [5]. Neither matches the drug combination, but both have no sexual side effects.
My call: for a man who wants the best hair regrowth and is willing to accept the risk, the combination of topical minoxidil and a low-dose topical 5α-reductase inhibitor (finasteride or dutasteride) is the most evidence-backed approach. Avoid oral finasteride unless you have weighed the real risk of persistent sexual dysfunction, which the industry trials systematically undercount. Confidence: moderate. The long-term safety data for topical finasteride is thin, and no trial has compared all options head-to-head past two years.
Sources used 11
-
Controversies in the treatment of androgenetic alopecia: The history of finasteride
This paper reviews the controversies surrounding the treatment of androgenetic alopecia with finasteride, highlighting its efficacy and the associated sexual dysfunction risks reported in clinical studies.
DOI: 10.1111/dth.12647 -
An observational retrospective evaluation of 79 young men with long‐term adverse effects after use of finasteride against androgenetic alopecia
This study evaluates the long-term sexual and non-sexual side effects experienced by 79 young men after using finasteride for androgenetic alopecia, revealing a high prevalence of symptoms such as loss of penis sensitivity and decreased ejaculatory force.
DOI: 10.1111/andr.12147 -
Efficacy and Safety of Finasteride Therapy for Androgenetic Alopecia
This systematic review evaluates the efficacy and safety of finasteride therapy for androgenetic alopecia in men, finding moderate-quality evidence that it increases hair count and improves patient and investigator assessments of hair appearance while also increasing the risk of…
DOI: 10.1001/archdermatol.2010.256 -
Finasteride and Dutasteride in the Treatment of Androgenetic Alopecia: Risk or Benefit?
This study evaluates the efficacy and safety of finasteride and dutasteride in treating androgenetic alopecia, highlighting their therapeutic benefits alongside potential sexual and psychological side effects.
DOI: 10.62742/2965-7911.2024.1.bjhh14 -
The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis
This systematic review and meta-analysis evaluates the efficacy of nonsurgical treatments for androgenetic alopecia, demonstrating that minoxidil, finasteride, and low-level laser light therapy significantly improve hair growth compared to placebo.
DOI: 10.1016/j.jaad.2017.02.054 -
Combined treatment with oral finasteride and topical minoxidil in male androgenetic alopecia: a randomized and comparative study in Chinese patients
This study evaluates the efficacy of oral finasteride, topical minoxidil, and their combination in treating male androgenetic alopecia in a cohort of 450 Chinese patients over 12 months, finding that the combination therapy yields the best results.
DOI: 10.1111/dth.12246 -
Comparative Efficacy of Various Treatment Regimens for Androgenetic Alopecia in Men
In a randomized clinical trial of 100 Indian men with androgenetic alopecia (Hamilton II–IV), finasteride alone or with minoxidil, and ketoconazole shampoo were compared over 12 months, with the combination of finasteride + minoxidil showing the most favorable outcomes.
DOI: 10.1111/j.1346-8138.2002.tb00314.x -
Comparison of the efficacy of platelet-rich plasma with topical minoxidil in treating patients with androgenetic alopecia: a systematic review of clinical trials
This systematic review of six randomized trials comparing platelet-rich plasma (PRP) to topical minoxidil (TM) for androgenetic alopecia (AGA) found PRP generally has comparable efficacy to TM, with some studies showing PRP superior for hair density or negative hair pull tests, …
DOI: 10.1093/skinhd/vzaf040 -
A randomized, double‐blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia
This study demonstrates that a topical solution of 0.25% finasteride combined with 3% minoxidil is significantly more effective than 3% minoxidil alone in promoting hair growth in men with androgenetic alopecia, while being well tolerated with minimal systemic effects.
DOI: 10.1111/jdv.15171 -
Platelet-Rich Plasma in the Management of Alopecia: A Systematic Review and Meta-Analysis of Clinical Evidence
A comprehensive systematic review and meta-analysis evaluating the safety and efficacy of platelet-rich plasma (PRP) for alopecia across subtypes, showing activated PRP increases hair density and is generally safe, with variable effects on hair thickness and mixed results versus…
DOI: 10.1007/s13555-025-01542-8 -
Effect of Pumpkin Seed Oil on Hair Growth in Men with Androgenetic Alopecia: A Randomized, Double‐Blind, Placebo‐Controlled Trial
This randomized, double-blind, placebo-controlled trial demonstrated that pumpkin seed oil significantly improves hair growth in men with androgenetic alopecia over 24 weeks compared to a placebo.
DOI: 10.1155/2014/549721